1-4 of 4
Jesper Skov Neergaard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessing Treatment Burden in Pediatric Hemophilia: Validation of the Observer-Reported Child Hemophilia Treatment Experience Measure (Child Hemo-TEM)

Meryl Brod, Donald M. Bushnell, Anne Kirstine Busk, Jesper Skov Neergaard
Journal: Blood
Blood (2023) 142 (Supplement 1): 2367.
https://doi.org/10.1182/blood-2023-172900
Published: 2023
Journal Articles

Understanding Treatment Burden in Pediatric Hemophilia: Development of the Child Hemophilia Treatment Experience Measure (Child Hemo-TEM)

Meryl Brod, Anne Kirstine Busk, Jesper Skov Neergaard
Journal: Blood
Blood (2023) 142 (Supplement 1): 3755.
https://doi.org/10.1182/blood-2023-174495
Published: 2023
Journal Articles

Treatment Burden and Patient Preference in Patients with Hemophilia A or B with Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

Kingsley Hampton, Paul Knoebl, Jan Odgaard-Jensen, Oleksandra Stasyshyn, Jay Jay Thaung Zaw, Jesper Skov Neergaard, Bulent Zulfikar
Journal: Blood
Blood (2022) 140 (Supplement 1): 5591–5592.
https://doi.org/10.1182/blood-2022-163468
Published: 2022
Journal Articles

Health-Related Quality of Life in Patients with Hemophilia A or B with Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

Amy D. Shapiro, Aby Abraham, Silvia Linari, Jesper Skov Neergaard, Jan Odgaard-Jensen, Jay Jay Thaung Zaw, Huyen Tran
Journal: Blood
Blood (2022) 140 (Supplement 1): 2732–2734.
https://doi.org/10.1182/blood-2022-166306
Published: 2022